{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:51:40Z","timestamp":1787698300473,"version":"build-2784847793"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s12264-024-01342-8","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:36:29Z","timestamp":1735950989000},"page":"676-690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors"],"prefix":"10.1007","volume":"41","author":[{"given":"Shufen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A.","family":"Moosavi-Movahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3560-3392","authenticated-orcid":false,"given":"Jianshe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","volume":"132","author":"MT Hayes","year":"2019","unstructured":"Hayes MT. Parkinson\u2019s disease and Parkinsonism. Am J Med 2019, 132: 802\u2013807.","journal-title":"Am J Med"},{"key":"1342_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/biomedicines8100416","volume":"8","author":"M Ejma","year":"2020","unstructured":"Ejma M, Madetko N, Brzecka A, Guranski K, Alster P, Misiuk-Hoj\u0142o M. The links between Parkinson\u2019s disease and cancer. Biomedicines 2020, 8: 416.","journal-title":"Biomedicines"},{"key":"1342_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol 2015, 14: 625\u2013639.","journal-title":"Lancet Neurol"},{"key":"1342_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.12659\/MSM.912840","volume":"25","author":"Z Zhou","year":"2019","unstructured":"Zhou Z, Zhou R, Zhang Z, Li K. The association between vitamin D status, vitamin D supplementation, sunlight exposure, and Parkinson\u2019s disease: A systematic review and meta-analysis. Med Sci Monit 2019, 25: 666\u2013674.","journal-title":"Med Sci Monit"},{"key":"1342_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.parkreldis.2013.02.006","volume":"19","author":"T M\u00fcller","year":"2013","unstructured":"M\u00fcller T, van Laar T, Cornblath DR, Odin P, Klostermann F, Grandas FJ, et al. Peripheral neuropathy in Parkinson\u2019s disease: Levodopa exposure and implications for duodenal delivery. Parkinsonism Relat Disord 2013, 19: 501\u2013507.","journal-title":"Parkinsonism Relat Disord"},{"key":"1342_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.parkreldis.2013.03.002","volume":"19","author":"YE Kim","year":"2013","unstructured":"Kim YE, Lee WW, Yun JY, Yang HJ, Kim HJ, Jeon BS. Musculoskeletal problems in Parkinson\u2019s disease: Neglected issues. Parkinsonism Relat Disord 2013, 19: 666\u2013669.","journal-title":"Parkinsonism Relat Disord"},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich SG, Savitt JM. Parkinson\u2019s disease. Med Clin N Am 2019, 103: 337\u2013350.","journal-title":"Parkinson\u2019s disease. Med Clin N Am"},{"key":"1342_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3233\/JPD-191900","volume":"10","author":"JLY Cheong","year":"2020","unstructured":"Cheong JLY, de Pablo-Fernandez E, Foltynie T, Noyce AJ. The association between type 2 diabetes mellitus and Parkinson\u2019s disease. J Parkinsons Dis 2020, 10: 775\u2013789.","journal-title":"J Parkinsons Dis"},{"key":"1342_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101979","volume":"89","author":"J Nowell","year":"2023","unstructured":"Nowell J, Blunt E, Gupta D, Edison P. Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 2023, 89: 101979.","journal-title":"Ageing Res Rev"},{"key":"1342_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","volume":"103","author":"L Guariguata","year":"2014","unstructured":"Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014, 103: 137\u2013149.","journal-title":"Diabetes Res Clin Pract"},{"key":"1342_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/384017","volume":"2012","author":"AI Duarte","year":"2012","unstructured":"Duarte AI, Moreira PI, Oliveira CR. Insulin in central nervous system: More than just a peripheral hormone. J Aging Res 2012, 2012: 384017.","journal-title":"J Aging Res"},{"key":"1342_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jcb.240480105","volume":"48","author":"CC Yip","year":"1992","unstructured":"Yip CC. The insulin-binding domain of insulin receptor is encoded by exon 2 and exon 3. J Cell Biochem 1992, 48: 19\u201325.","journal-title":"J Cell Biochem"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1086\/421528","volume":"74","author":"RS Savkur","year":"2004","unstructured":"Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LPW, et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004, 74: 1309\u20131313.","journal-title":"Am J Hum Genet"},{"key":"1342_CR14","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1128\/MCB.19.5.3278","volume":"19","author":"F Frasca","year":"1999","unstructured":"Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, et al. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999, 19: 3278\u20133288.","journal-title":"Mol Cell Biol"},{"key":"1342_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1172\/JCI117447","volume":"94","author":"Z Huang","year":"1994","unstructured":"Huang Z, Bodkin NL, Ortmeyer HK, Hansen BC, Shuldiner AR. Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey. J Clin Invest 1994, 94: 1289\u20131296.","journal-title":"J Clin Invest"},{"key":"1342_CR16","doi-asserted-by":"publisher","first-page":"9987","DOI":"10.3390\/ijms22189987","volume":"22","author":"A S\u0119dzikowska","year":"2021","unstructured":"S\u0119dzikowska A, Szablewski L. Insulin and insulin resistance in Alzheimer\u2019s disease. Int J Mol Sci 2021, 22: 9987.","journal-title":"Int J Mol Sci"},{"key":"1342_CR17","doi-asserted-by":"publisher","first-page":"1149239","DOI":"10.3389\/fendo.2023.1149239","volume":"14","author":"X Zhao","year":"2023","unstructured":"Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol 2023, 14: 1149239.","journal-title":"Front Endocrinol"},{"key":"1342_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","volume":"19","author":"D Kellar","year":"2020","unstructured":"Kellar D, Craft S. Brain insulin resistance in Alzheimer\u2019s disease and related disorders: Mechanisms and therapeutic approaches. Lancet Neurol 2020, 19: 758\u2013766.","journal-title":"Lancet Neurol"},{"key":"1342_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer\u2019s disease. Neurochem Int 2020, 135: 104707.","journal-title":"Neurochem Int"},{"key":"1342_CR20","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4103\/1673-5374.332122","volume":"17","author":"CM Labandeira","year":"2022","unstructured":"Labandeira CM, Fraga-Bau A, Arias Ron D, Alvarez-Rodriguez E, Vicente-Alba P, Lago-Garma J, et al. Parkinson\u2019s disease and diabetes mellitus: Common mechanisms and treatment repurposing. Neural Regen Res 2022, 17: 1652\u20131658.","journal-title":"Neural Regen Res"},{"key":"1342_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold SE, Arvanitakis Z, Macauley-Rambach SL, Koenig AM, Wang HY, Ahima RS, et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: Concepts and conundrums. Nat Rev Neurol 2018, 14: 168\u2013181.","journal-title":"Nat Rev Neurol"},{"key":"1342_CR22","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci 2018, 14: 1483\u20131496.","journal-title":"Int J Biol Sci"},{"key":"1342_CR23","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s12640-019-0003-y","volume":"35","author":"SN Rai","year":"2019","unstructured":"Rai SN, Dilnashin H, Birla H, Singh SS, Zahra W, Rathore AS, et al. The role of PI3K\/akt and ERK in neurodegenerative disorders. Neurotox Res 2019, 35: 775\u2013795.","journal-title":"Neurotox Res"},{"key":"1342_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/diseases7010022","volume":"7","author":"S Matsuda","year":"2019","unstructured":"Matsuda S, Ikeda Y, Murakami M, Nakagawa Y, Tsuji A, Kitagishi Y. Roles of PI3K\/AKT\/GSK3 pathway involved in psychiatric illnesses. Diseases 2019, 7: 22.","journal-title":"Diseases"},{"key":"1342_CR25","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1093\/emboj\/17.22.6649","volume":"17","author":"H Shima","year":"1998","unstructured":"Shima H, Pende M, Chen Y, Fumagalli S, Thomas G, Kozma SC. Disruption of the p70(s6k)\/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J 1998, 17: 6649\u20136659.","journal-title":"EMBO J"},{"key":"1342_CR26","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1093\/emboj\/cdf387","volume":"21","author":"MA Lawlor","year":"2002","unstructured":"Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tait V, Malone L, et al. Essential role of PDK1 in regulating cell size and development in mice. EMBO J 2002, 21: 3728\u20133738.","journal-title":"EMBO J"},{"key":"1342_CR27","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11010-022-04587-x","volume":"478","author":"K Ramasubbu","year":"2023","unstructured":"Ramasubbu K, Devi Rajeswari V. Impairment of insulin signaling pathway PI3K\/Akt\/mTOR and insulin resistance induced AGEs on diabetes mellitus and neurodegenerative diseases: A perspective review. Mol Cell Biochem 2023, 478: 1307\u20131324.","journal-title":"Mol Cell Biochem"},{"key":"1342_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tibs.2014.12.003","volume":"40","author":"JE Burke","year":"2015","unstructured":"Burke JE, Williams RL. Synergy in activating class I PI3Ks. Trends Biochem Sci 2015, 40: 88\u2013100.","journal-title":"Trends Biochem Sci"},{"key":"1342_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.819128","volume":"12","author":"Y Peng","year":"2022","unstructured":"Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/akt\/mTOR pathway and its role in cancer therapeutics: Are we making headway? Front Oncol 2022, 12: 819128.","journal-title":"Front Oncol"},{"key":"1342_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","volume":"23","author":"B Kim","year":"2012","unstructured":"Kim B, Feldman EL. Insulin resistance in the nervous system. Trends Endocrinol Metab 2012, 23: 133\u2013141.","journal-title":"Trends Endocrinol Metab"},{"key":"1342_CR31","volume":"2012","author":"Y Kitagishi","year":"2012","unstructured":"Kitagishi Y, Kobayashi M, Kikuta K, Matsuda S. Roles of PI3K\/AKT\/GSK3\/mTOR pathway in cell signaling of mental illnesses. Depress Res Treat 2012, 2012: 752563.","journal-title":"Depress Res Treat"},{"key":"1342_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.brainresbull.2020.08.001","volume":"164","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Bishnoi M, Sah SP. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer\u2019s disease through modulation of brain insulin resistance induced tau pathology. Brain Res Bull 2020, 164: 83\u201397.","journal-title":"Brain Res Bull"},{"key":"1342_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102270","volume":"214","author":"U Sengupta","year":"2022","unstructured":"Sengupta U, Kayed R. Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases. Prog Neurobiol 2022, 214: 102270.","journal-title":"Prog Neurobiol"},{"key":"1342_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"L Yang","year":"2018","unstructured":"Yang L, Wang H, Liu L, Xie A. The role of insulin\/IGF-1\/PI3K\/akt\/GSK3\u03b2 signaling in Parkinson\u2019s disease dementia. Front Neurosci 2018, 12: 73.","journal-title":"Front Neurosci"},{"key":"1342_CR35","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1523\/JNEUROSCI.0625-19.2019","volume":"39","author":"S Luo","year":"2019","unstructured":"Luo S, Kang SS, Wang ZH, Liu X, Day JX, Wu Z, et al. Akt phosphorylates NQO1 and triggers its degradation, abolishing its antioxidative activities in Parkinson\u2019s disease. J Neurosci 2019, 39: 7291\u20137305.","journal-title":"J Neurosci"},{"key":"1342_CR36","doi-asserted-by":"publisher","first-page":"1226655","DOI":"10.3389\/fendo.2023.1226655","volume":"14","author":"TKC Le","year":"2023","unstructured":"Le TKC, Dao XD, Nguyen DV, Luu DH, Bui TMH, Le TH, et al. Insulin signaling and its application. Front Endocrinol 2023, 14: 1226655.","journal-title":"Front Endocrinol"},{"key":"1342_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110347","volume":"371","author":"SA Ahmed","year":"2023","unstructured":"Ahmed SA, Sarma P, Barge SR, Swargiary D, Devi GS, Borah JC. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK\/FoxO1\/AKT\/GSK3\u03b2 signaling cascade. Chem Biol Interact 2023, 371: 110347.","journal-title":"Chem Biol Interact"},{"key":"1342_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2217\/fnl.12.72","volume":"7","author":"ZZ Chong","year":"2012","unstructured":"Chong ZZ, Shang YC, Wang S, Maiese K. A critical kinase cascade in neurological disorders: PI 3-K, Akt, and mTOR. Future Neurol 2012, 7: 733\u2013748.","journal-title":"Future Neurol"},{"key":"1342_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110707","volume":"108","author":"M Liang","year":"2023","unstructured":"Liang M, Wang L, Wang W. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE2-EP4 receptor-AKT signaling in a type 2 diabetes mellitus mouse model. Cell Signal 2023, 108: 110707.","journal-title":"Cell Signal"},{"key":"1342_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.648636","volume":"12","author":"HZ Long","year":"2021","unstructured":"Long HZ, Cheng Y, Zhou ZW, Luo HY, Wen DD, Gao LC. PI3K\/AKT signal pathway: A target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease. Front Pharmacol 2021, 12: 648636.","journal-title":"Front Pharmacol"},{"key":"1342_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147703","volume":"1773","author":"X Li","year":"2021","unstructured":"Li X, He Q, Zhao N, Chen X, Li T, Cheng B. High intensity interval training ameliorates cognitive impairment in T2DM mice possibly by improving PI3K\/Akt\/mTOR Signaling-regulated autophagy in the hippocampus. Brain Res 2021, 1773: 147703.","journal-title":"Brain Res"},{"key":"1342_CR42","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell 2012, 149: 274\u2013293.","journal-title":"Cell"},{"key":"1342_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.diabres.2017.04.002","volume":"128","author":"X Yin","year":"2017","unstructured":"Yin X, Xu Z, Zhang Z, Li L, Pan Q, Zheng F, et al. Association of PI3K\/AKT\/mTOR pathway genetic variants with type 2 diabetes mellitus in Chinese. Diabetes Res Clin Pract 2017, 128: 127\u2013135.","journal-title":"Diabetes Res Clin Pract"},{"key":"1342_CR44","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3233\/JAD-161029","volume":"56","author":"HK Lee","year":"2017","unstructured":"Lee HK, Kwon B, Lemere CA, de la Monte S, Itamura K, Ha AY, et al. mTORC2 (rictor) in Alzheimer\u2019s disease and reversal of amyloid-\u03b2 expression-induced insulin resistance and toxicity in rat primary cortical neurons. J Alzheimers Dis 2017, 56: 1015\u20131036.","journal-title":"J Alzheimers Dis"},{"key":"1342_CR45","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2142\/biophysico.16.0_80","volume":"16","author":"Y Hosoe","year":"2019","unstructured":"Hosoe Y, Numoto N, Inaba S, Ogawa S, Morii H, Abe R, et al. Structural and functional properties of Grb2 SH2 dimer in CD28 binding. Biophys Physicobiol 2019, 16: 80\u201388.","journal-title":"Biophys Physicobiol"},{"key":"1342_CR46","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1074\/mcp.M800407-MCP200","volume":"8","author":"S Hanke","year":"2009","unstructured":"Hanke S, Mann M. The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Mol Cell Proteomics 2009, 8: 519\u2013534.","journal-title":"Mol Cell Proteomics"},{"key":"1342_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux pp. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011, 75: 50\u201383.","journal-title":"Microbiol Mol Biol Rev"},{"key":"1342_CR48","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.3390\/cells11101602","volume":"11","author":"Z Huang","year":"2022","unstructured":"Huang Z, Tian Z, Zhao Y, Zhu F, Liu W, Wang X. MAPK signaling pathway is essential for female reproductive regulation in the cabbage beetle. Colaphellus bowringi. Cells 2022, 11: 1602.","journal-title":"Colaphellus bowringi. Cells"},{"key":"1342_CR49","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/antiox12040955","volume":"12","author":"S Chakrabarti","year":"2023","unstructured":"Chakrabarti S, Bisaglia M. Oxidative stress and neuroinflammation in Parkinson\u2019s disease: The role of dopamine oxidation products. Antioxidants 2023, 12: 955.","journal-title":"Antioxidants"},{"key":"1342_CR50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10495-008-0309-3","volume":"14","author":"OA Levy","year":"2009","unstructured":"Levy OA, Malagelada C, Greene LA. Cell death pathways in Parkinson\u2019s disease: Proximal triggers, distal effectors, and final steps. Apoptosis 2009, 14: 478\u2013500.","journal-title":"Apoptosis"},{"key":"1342_CR51","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","volume":"29","author":"A Klegeris","year":"2008","unstructured":"Klegeris A, Pelech S, Giasson BI, Maguire J, Zhang H, McGeer EG, et al. Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia. Neurobiol Aging 2008, 29: 739\u2013752.","journal-title":"Neurobiol Aging"},{"key":"1342_CR52","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","volume":"1802","author":"EK Kim","year":"2010","unstructured":"Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta 2010, 1802: 396\u2013405.","journal-title":"Biochim Biophys Acta"},{"key":"1342_CR53","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","volume":"11","author":"K Zhang","year":"2021","unstructured":"Zhang K, Zhu S, Li J, Jiang T, Feng L, Pei J, et al. Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson\u2019s disease. Acta Pharm Sin B 2021, 11: 3015\u20133034.","journal-title":"Acta Pharm Sin B"},{"key":"1342_CR54","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2337\/diabetes.49.6.896","volume":"49","author":"PA Lochhead","year":"2000","unstructured":"Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 2000, 49: 896\u2013903.","journal-title":"Diabetes"},{"key":"1342_CR55","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nature07349","volume":"456","author":"Y Liu","year":"2008","unstructured":"Liu Y, Dentin R, Chen D, Hedrick S, Ravnskjaer K, Schenk S, et al. A fasting inducible switch modulates gluconeogenesis via activator\/coactivator exchange. Nature 2008, 456: 269\u2013273.","journal-title":"Nature"},{"key":"1342_CR56","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310: 1642\u20131646.","journal-title":"Science"},{"key":"1342_CR57","doi-asserted-by":"publisher","first-page":"33902","DOI":"10.1074\/jbc.M802537200","volume":"283","author":"N Horike","year":"2008","unstructured":"Horike N, Sakoda H, Kushiyama A, Ono H, Fujishiro M, Kamata H, et al. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver. J Biol Chem 2008, 283: 33902\u201333910.","journal-title":"J Biol Chem"},{"key":"1342_CR58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2009.03.012","volume":"9","author":"BB Zhang","year":"2009","unstructured":"Zhang BB, Zhou G, Li C. AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab 2009, 9: 407\u2013416.","journal-title":"Cell Metab"},{"key":"1342_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/biof.1248","volume":"41","author":"X Liang","year":"2015","unstructured":"Liang X, Zhang T, Shi L, Kang C, Wan J, Zhou Y, et al. Ampelopsin protects endothelial cells from hyperglycemia-induced oxidative damage by inducing autophagy via the AMPK signaling pathway. BioFactors 2015, 41: 463\u2013475.","journal-title":"BioFactors"},{"key":"1342_CR60","doi-asserted-by":"publisher","first-page":"047","DOI":"10.1093\/ijnp\/pyw047","volume":"19","author":"M Lu","year":"2016","unstructured":"Lu M, Su C, Qiao C, Bian Y, Ding J, Hu G. Metformin prevents dopaminergic neuron death in MPTP\/P-induced mouse model of Parkinson\u2019s disease via autophagy and mitochondrial ROS clearance. Int J Neuropsychopharmacol 2016, 19: 047.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1342_CR61","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.cell.2016.07.028","volume":"166","author":"C Garc\u00eda-C\u00e1ceres","year":"2016","unstructured":"Garc\u00eda-C\u00e1ceres C, Quarta C, Varela L, Gao Y, Gruber T, Legutko B, et al. Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell 2016, 166: 867\u2013880.","journal-title":"Cell"},{"key":"1342_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1139\/cjpp-2015-0242","volume":"94","author":"ES Gad","year":"2016","unstructured":"Gad ES, Zaitone SA, Moustafa YM. Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats. Can J Physiol Pharmacol 2016, 94: 819\u2013828.","journal-title":"Can J Physiol Pharmacol"},{"key":"1342_CR63","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s12264-022-00957-z","volume":"39","author":"R Wang","year":"2023","unstructured":"Wang R, Ren H, Kaznacheyeva E, Lu X, Wang G. Association of glial activation and \u03b1-synuclein pathology in Parkinson\u2019s disease. Neurosci Bull 2023, 39: 479\u2013490.","journal-title":"Neurosci Bull"},{"key":"1342_CR64","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1093\/brain\/awx044","volume":"140","author":"F Bassil","year":"2017","unstructured":"Bassil F, Canron MH, Vital A, Bezard E, Li Y, Greig NH, et al. Insulin resistance and exendin-4 treatment for multiple system atrophy. Brain 2017, 140: 1420\u20131436.","journal-title":"Brain"},{"key":"1342_CR65","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1210\/endo-121-4-1562","volume":"121","author":"GA Werther","year":"1987","unstructured":"Werther GA, Hogg A, Oldfield BJ, McKinley MJ, Figdor R, Allen AM, et al. Localization and characterization of insulin receptors in rat brain and pituitary gland using in vitro autoradiography and computerized densitometry. Endocrinology 1987, 121: 1562\u20131570.","journal-title":"Endocrinology"},{"key":"1342_CR66","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/272827a0","volume":"272","author":"J Havrankova","year":"1978","unstructured":"Havrankova J, Roth J, Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272: 827\u2013829.","journal-title":"Nature"},{"key":"1342_CR67","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/cne.903330306","volume":"333","author":"S Kar","year":"1993","unstructured":"Kar S, Chabot JG, Quirion R. Quantitative autoradiographic localization of[125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and[125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol 1993, 333: 375\u2013397.","journal-title":"J Comp Neurol"},{"key":"1342_CR68","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.euroneuro.2014.01.020","volume":"24","author":"H Werner","year":"2014","unstructured":"Werner H, LeRoith D. Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects. Eur Neuropsychopharmacol 2014, 24: 1947\u20131953.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1342_CR69","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1172\/JCI109504","volume":"64","author":"J Havrankova","year":"1979","unstructured":"Havrankova J, Roth J, Brownstein MJ. Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest 1979, 64: 636\u2013642.","journal-title":"J Clin Invest"},{"key":"1342_CR70","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/BF00254492","volume":"20","author":"J Havrankova","year":"1981","unstructured":"Havrankova J, Brownstein M, Roth J. Insulin and insulin receptors in rodent brain. Diabetologia 1981, 20: 268\u2013273.","journal-title":"Diabetologia"},{"key":"1342_CR71","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0304-3940(96)12357-0","volume":"204","author":"M Takahashi","year":"1996","unstructured":"Takahashi M, Yamada T, Tooyama I, Moroo I, Kimura H, Yamamoto T, et al. Insulin receptor mRNA in the substantia nigra in Parkinson\u2019s disease. Neurosci Lett 1996, 204: 201\u2013204.","journal-title":"Neurosci Lett"},{"key":"1342_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.4103\/1673-5374.320965","volume":"17","author":"A De Iuliis","year":"2022","unstructured":"De Iuliis A, Montinaro E, Fatati G, Plebani M, Colosimo C. Diabetes mellitus and Parkinson\u2019s disease: Dangerous liaisons between insulin and dopamine. Neural Regen Res 2022, 17: 523\u2013533.","journal-title":"Neural Regen Res"},{"key":"1342_CR73","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131682","volume":"4","author":"CH Mazucanti","year":"2019","unstructured":"Mazucanti CH, Liu QR, Lang D, Huang N, O\u2019Connell JF, Camandola S, et al. Release of insulin produced by the choroid plexis is regulated by serotonergic signaling. JCI Insight 2019, 4: e131682.","journal-title":"JCI Insight"},{"key":"1342_CR74","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1083\/jcb.201802095","volume":"217","author":"VL Tokarz","year":"2018","unstructured":"Tokarz VL, MacDonald PE, Klip A. The cell biology of systemic insulin function. J Cell Biol 2018, 217: 2273\u20132289.","journal-title":"J Cell Biol"},{"key":"1342_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101999","volume":"90","author":"Y Tian","year":"2023","unstructured":"Tian Y, Jing G, Zhang M. Insulin-degrading enzyme: Roles and pathways in ameliorating cognitive impairment associated with Alzheimer\u2019s disease and diabetes. Ageing Res Rev 2023, 90: 101999.","journal-title":"Ageing Res Rev"},{"key":"1342_CR76","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/15548627.2016.1159375","volume":"12","author":"SM Son","year":"2016","unstructured":"Son SM, Cha MY, Choi H, Kang S, Choi H, Lee MS, et al. Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. Autophagy 2016, 12: 784\u2013800.","journal-title":"Autophagy"},{"key":"1342_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.135412","volume":"5","author":"J Lee","year":"2020","unstructured":"Lee J, Kim K, Cho JH, Bae JY, O\u2019Leary TP, Johnson JD, et al. Insulin synthesized in the paraventricular nucleus of the hypothalamus regulates pituitary growth hormone production. JCI Insight 2020, 5: e135412.","journal-title":"JCI Insight"},{"key":"1342_CR78","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1152\/ajpendo.00642.2020","volume":"321","author":"R Agrawal","year":"2021","unstructured":"Agrawal R, Reno CM, Sharma S, Christensen C, Huang Y, Fisher SJ. Insulin action in the brain regulates both central and peripheral functions. Am J Physiol Endocrinol Metab 2021, 321: E156\u2013E163.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1342_CR79","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1007\/s12035-023-03359-y","volume":"60","author":"SS Sabari","year":"2023","unstructured":"Sabari SS, Balasubramani K, Iyer M, Sureshbabu HW, Venkatesan D, Gopalakrishnan AV, et al. Type 2 diabetes (T2DM) and Parkinson\u2019s disease (PD): A mechanistic approach. Mol Neurobiol 2023, 60: 4547\u20134573.","journal-title":"Mol Neurobiol"},{"key":"1342_CR80","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.2337\/db10-0401","volume":"59","author":"KA Diggs-Andrews","year":"2010","unstructured":"Diggs-Andrews KA, Zhang X, Song Z, Daphna-Iken D, Routh VH, Fisher SJ. Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia. Diabetes 2010, 59: 2271\u20132280.","journal-title":"Diabetes"},{"key":"1342_CR81","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/nature03439","volume":"434","author":"A Pocai","year":"2005","unstructured":"Pocai A, Lam TKT, Gutierrez-Juarez R, Obici S, Schwartz GJ, Bryan J, et al. Hypothalamic K(ATP) channels control hepatic glucose production. Nature 2005, 434: 1026\u20131031.","journal-title":"Nature"},{"key":"1342_CR82","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38704","volume":"7","author":"GT Dodd","year":"2018","unstructured":"Dodd GT, Michael NJ, Lee-Young RS, Mangiafico SP, Pryor JT, Munder AC, et al. Insulin regulates POMC neuronal plasticity to control glucose metabolism. Elife 2018, 7: e38704.","journal-title":"Elife"},{"key":"1342_CR83","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.celrep.2016.02.032","volume":"14","author":"K Kimura","year":"2016","unstructured":"Kimura K, Tanida M, Nagata N, Inaba Y, Watanabe H, Nagashimada M, et al. Central insulin action activates kupffer cells by suppressing hepatic vagal activation via the nicotinic alpha 7 acetylcholine receptor. Cell Rep 2016, 14: 2362\u20132374.","journal-title":"Cell Rep"},{"key":"1342_CR84","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cmet.2011.01.008","volume":"13","author":"T Scherer","year":"2011","unstructured":"Scherer T, O\u2019Hare J, Diggs-Andrews K, Schweiger M, Cheng B, Lindtner C, et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 2011, 13: 183\u2013194.","journal-title":"Cell Metab"},{"key":"1342_CR85","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1126\/science.289.5487.2122","volume":"289","author":"JC Br\u00fcning","year":"2000","unstructured":"Br\u00fcning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289: 2122\u20132125.","journal-title":"Science"},{"key":"1342_CR86","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tins.2022.03.001","volume":"45","author":"W Chen","year":"2022","unstructured":"Chen W, Cai W, Hoover B, Kahn CR. Insulin action in the brain: Cell types, circuits, and diseases. Trends Neurosci 2022, 45: 384\u2013400.","journal-title":"Trends Neurosci"},{"key":"1342_CR87","doi-asserted-by":"crossref","unstructured":"Collaborators G2N. (2019) Global, regional, and national burden of neurological disorders, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol , 18: 459\u2013480.","DOI":"10.1016\/S1474-4422(18)30499-X"},{"key":"1342_CR88","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 2021, 20: 385\u2013397.","journal-title":"Lancet Neurol"},{"issue":"146","key":"1342_CR89","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. Insulin resistance and Parkinson\u2019s disease: A new target for disease modification? Prog Neurobiol 2016, 145(146): 98\u2013120.","journal-title":"Prog Neurobiol"},{"key":"1342_CR90","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(01)02344-8","volume":"316","author":"D Offen","year":"2001","unstructured":"Offen D, Shtaif B, Hadad D, Weizman A, Melamed E, Gil-Ad I. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: Possible implications for Parkinson\u2019s disease. Neurosci Lett 2001, 316: 129\u2013132.","journal-title":"Neurosci Lett"},{"key":"1342_CR91","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3233\/JPD-202138","volume":"10","author":"ML Erb","year":"2020","unstructured":"Erb ML, Moore DJ. LRRK2 and the endolysosomal system in Parkinson\u2019s disease. J Parkinsons Dis 2020, 10: 1271\u20131291.","journal-title":"J Parkinsons Dis"},{"key":"1342_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179082","volume":"12","author":"M Rassu","year":"2017","unstructured":"Rassu M, del Giudice MG, Sanna S, Taymans JM, Morari M, Brugnoli A, et al. Role of LRRK2 in the regulation of dopamine receptor trafficking. PLoS One 2017, 12: e0179082.","journal-title":"PLoS One"},{"key":"1342_CR93","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1038\/s41598-019-40808-y","volume":"9","author":"N Funk","year":"2019","unstructured":"Funk N, Munz M, Ott T, Brockmann K, Wenninger-Weinzierl A, K\u00fchn R, et al. The Parkinson\u2019s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4. Sci Rep 2019, 9: 4515.","journal-title":"Sci Rep"},{"key":"1342_CR94","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3389\/fnins.2019.00868","volume":"13","author":"F Fiory","year":"2019","unstructured":"Fiory F, Perruolo G, Cimmino I, Cabaro S, Pignalosa FC, Miele C, et al. The relevance of insulin action in the dopaminergic system. Front Neurosci 2019, 13: 868.","journal-title":"Front Neurosci"},{"key":"1342_CR95","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.3390\/nu15163585","volume":"15","author":"VA Ruiz-Pozo","year":"2023","unstructured":"Ruiz-Pozo VA, Tamayo-Trujillo R, Cadena-Ullauri S, Frias-Toral E, Guevara-Ram\u00edrez P, Paz-Cruz E, et al. The molecular mechanisms of the relationship between insulin resistance and Parkinson\u2019s disease pathogenesis. Nutrients 2023, 15: 3585.","journal-title":"Nutrients"},{"key":"1342_CR96","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s12264-022-00867-0","volume":"38","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Ma X, Song N, Xie J. Expanding views of mitochondria in Parkinson\u2019s disease: Focusing on PINK1 and GBA1 mutations. Neurosci Bull 2022, 38: 825\u2013828.","journal-title":"Neurosci Bull"},{"key":"1342_CR97","doi-asserted-by":"publisher","first-page":"44373","DOI":"10.1038\/srep44373","volume":"7","author":"B Koentjoro","year":"2017","unstructured":"Koentjoro B, Park JS, Sue CM. Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson\u2019s disease. Sci Rep 2017, 7: 44373.","journal-title":"Sci Rep"},{"key":"1342_CR98","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3390\/cells9030740","volume":"9","author":"CT Hong","year":"2020","unstructured":"Hong CT, Chen KY, Wang W, Chiu JY, Wu D, Chao TY, et al. Insulin resistance promotes Parkinson\u2019s disease through aberrant expression of \u03b1-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling. Cells 2020, 9: 740.","journal-title":"Cells"},{"key":"1342_CR99","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2017.02.010","volume":"305","author":"J Chen","year":"2017","unstructured":"Chen J, Sun Z, Jin M, Tu Y, Wang S, Yang X, et al. Inhibition of AGEs\/RAGE\/Rho\/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1\/M2 polarization through the NF-\u03baB pathway. J Neuroimmunol 2017, 305: 108\u2013114.","journal-title":"J Neuroimmunol"},{"key":"1342_CR100","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H, Lee Y, Lee YI, Pletinkova O, et al. PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease. Cell 2011, 144: 689\u2013702.","journal-title":"Cell"},{"key":"1342_CR101","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.2337\/db15-1428","volume":"65","author":"M Sajan","year":"2016","unstructured":"Sajan M, Hansen B, Ivey R 3rd, Sajan J, Ari C, Song S, et al. Brain insulin signaling is increased in insulin-resistant states and decreases in FOXOs and PGC-1\u03b1 and increases in A\u03b21-40\/42 and phospho-tau may abet alzheimer development. Diabetes 2016, 65: 1892\u20131903.","journal-title":"Diabetes"},{"key":"1342_CR102","first-page":"582","volume":"26","author":"L Zheng","year":"2017","unstructured":"Zheng L, Bernard-Marissal N, Moullan N, D\u2019Amico D, Auwerx J, Moore DJ, et al. Parkin functionally interacts with PGC-1\u03b1 to preserve mitochondria and protect dopaminergic neurons. Hum Mol Genet 2017, 26: 582\u2013598.","journal-title":"Hum Mol Genet"},{"key":"1342_CR103","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.3390\/ijms21124471","volume":"21","author":"H Albert-Gasc\u00f3","year":"2020","unstructured":"Albert-Gasc\u00f3 H, Ros-Bernal F, Castillo-G\u00f3mez E, Olucha-Bordonau FE. MAP\/ERK signaling in developing cognitive and emotional function and its effect on pathological and neurodegenerative processes. Int J Mol Sci 2020, 21: 4471.","journal-title":"Int J Mol Sci"},{"key":"1342_CR104","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1046\/j.1471-4159.2001.00304.x","volume":"77","author":"SM Kulich","year":"2001","unstructured":"Kulich SM, Chu CT. Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: Implications for Parkinson\u2019s disease. J Neurochem 2001, 77: 1058\u20131066.","journal-title":"J Neurochem"},{"key":"1342_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.46","volume":"3","author":"JH Zhu","year":"2012","unstructured":"Zhu JH, Gusdon AM, Cimen H, van Houten B, Koc E, Chu CT. Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: Dual roles for ERK1\/2. Cell Death Dis 2012, 3: e312.","journal-title":"Cell Death Dis"},{"key":"1342_CR106","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbi.2019.10.015","volume":"83","author":"Y Li","year":"2020","unstructured":"Li Y, Chen N, Wu C, Lu Y, Gao G, Duan C, et al. Galectin-1 attenuates neurodegeneration in Parkinson\u2019s disease model by modulating microglial MAPK\/I\u03baB\/NF\u03baB axis through its carbohydrate-recognition domain. Brain Behav Immun 2020, 83: 214\u2013225.","journal-title":"Brain Behav Immun"},{"key":"1342_CR107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-022-04477-2","volume":"478","author":"Y Li","year":"2023","unstructured":"Li Y, Hei H, Zhang S, Gong W, Liu Y, Qin J. PGC-1\u03b1 participates in tumor chemoresistance by regulating glucose metabolism and mitochondrial function. Mol Cell Biochem 2023, 478: 47\u201357.","journal-title":"Mol Cell Biochem"},{"key":"1342_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102363","volume":"54","author":"XC Ni","year":"2022","unstructured":"Ni XC, Wang HF, Cai YY, Yang D, Alolga RN, Liu B, et al. Ginsenoside Rb1 inhibits astrocyte activation and promotes transfer of astrocytic mitochondria to neurons against ischemic stroke. Redox Biol 2022, 54: 102363.","journal-title":"Redox Biol"},{"issue":"Suppl 2","key":"1342_CR109","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jnc.13486","volume":"139","author":"JP Bola\u00f1os","year":"2016","unstructured":"Bola\u00f1os JP. Bioenergetics and redox adaptations of astrocytes to neuronal activity. J Neurochem 2016, 139(Suppl 2): 115\u2013125.","journal-title":"J Neurochem"},{"key":"1342_CR110","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jalz.2013.12.006","volume":"10","author":"C H\u00f6lscher","year":"2014","unstructured":"H\u00f6lscher C. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer\u2019s disease. Alzheimers Dement 2014, 10: S33\u2013S37.","journal-title":"Alzheimers Dement"},{"key":"1342_CR111","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.neuron.2023.12.012","volume":"112","author":"W Ren","year":"2024","unstructured":"Ren W, Chen J, Wang W, Li Q, Yin X, Zhuang G, et al. Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function. Neuron 2024, 112: 972-990.e8.","journal-title":"Neuron"},{"key":"1342_CR112","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/pr.115.011395","volume":"68","author":"C de Graaf","year":"2016","unstructured":"de Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, et al. Glucagon-like peptide-1 and its class B G protein-coupled receptors: A long March to therapeutic successes. Pharmacol Rev 2016, 68: 954\u20131013.","journal-title":"Pharmacol Rev"},{"key":"1342_CR113","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tem.2016.10.001","volume":"28","author":"G Muscogiuri","year":"2017","unstructured":"Muscogiuri G, DeFronzo RA, Gastaldelli A, Holst JJ. Glucagon-like peptide-1 and the central\/peripheral nervous system: Crosstalk in diabetes. Trends Endocrinol Metab 2017, 28: 88\u2013103.","journal-title":"Trends Endocrinol Metab"},{"key":"1342_CR114","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/jnr.21483","volume":"86","author":"G Bertilsson","year":"2008","unstructured":"Bertilsson G, Patrone C, Zachrisson O, Andersson A, Dannaeus K, Heidrich J, et al. Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson\u2019s disease. J Neurosci Res 2008, 86: 326\u2013338.","journal-title":"J Neurosci Res"},{"key":"1342_CR115","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.drudis.2016.01.013","volume":"21","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson\u2019s disease: Mechanisms of action. Drug Discov Today 2016, 21: 802\u2013818.","journal-title":"Drug Discov Today"},{"key":"1342_CR116","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011, 13: 1016\u20131023.","journal-title":"Nat Cell Biol"},{"key":"1342_CR117","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.12659\/MSM.911250","volume":"25","author":"M Zhao","year":"2019","unstructured":"Zhao M, Li XW, Chen DZ, Hao F, Tao SX, Yu HY, et al. Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK\/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress. Med Sci Monit 2019, 25: 2186\u20132194.","journal-title":"Med Sci Monit"},{"key":"1342_CR118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neures.2019.12.017","volume":"162","author":"N Saewanee","year":"2021","unstructured":"Saewanee N, Praputpittaya T, Malaiwong N, Chalorak P, Meemon K. Neuroprotective effect of metformin on dopaminergic neurodegeneration and \u03b1-synuclein aggregation in C. elegans model of Parkinson\u2019s disease. Neurosci Res 2021, 162: 13\u201321.","journal-title":"Neurosci Res"},{"key":"1342_CR119","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","volume":"125","author":"N Katila","year":"2017","unstructured":"Katila N, Bhurtel S, Shadfar S, Srivastav S, Neupane S, Ojha U, et al. Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 2017, 125: 396\u2013407.","journal-title":"Neuropharmacology"},{"key":"1342_CR120","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/brain\/awx056","volume":"140","author":"HV Miranda","year":"2017","unstructured":"Miranda HV, Szego \u00c9M, Oliveira LMA, Breda C, Darendelioglu E, de Oliveira RM, et al. Glycation potentiates \u03b1-synuclein-associated neurodegeneration in synucleinopathies. Brain 2017, 140: 1399\u20131419.","journal-title":"Brain"},{"key":"1342_CR121","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, et al. Disruption of mitochondrial complex I induces progressive Parkinsonism. Nature 2021, 599: 650\u2013656.","journal-title":"Nature"},{"key":"1342_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2021.105120","volume":"148","author":"N Katila","year":"2021","unstructured":"Katila N, Bhurtel S, Park PH, Choi DY. Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT\/Nrf2 pathway. Neurochem Int 2021, 148: 105120.","journal-title":"Neurochem Int"},{"key":"1342_CR123","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41531-022-00406-8","volume":"8","author":"H Zhao","year":"2022","unstructured":"Zhao H, Zhuo L, Sun Y, Shen P, Lin H, Zhan S. Thiazolidinedione use and risk of Parkinson\u2019s disease in patients with type 2 diabetes mellitus. NPJ Parkinsons Dis 2022, 8: 138.","journal-title":"NPJ Parkinsons Dis"},{"key":"1342_CR124","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1046\/j.1471-4159.2002.00990.x","volume":"82","author":"T Breidert","year":"2002","unstructured":"Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC. Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson\u2019s disease. J Neurochem 2002, 82: 615\u2013624.","journal-title":"J Neurochem"},{"key":"1342_CR125","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","volume":"88","author":"T Dehmer","year":"2004","unstructured":"Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB. Protection by pioglitazone in the MPTP model of Parkinson\u2019s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 2004, 88: 494\u2013501.","journal-title":"J Neurochem"},{"key":"1342_CR126","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1111\/j.1460-9568.2009.06657.x","volume":"29","author":"N Schintu","year":"2009","unstructured":"Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, et al. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson\u2019s disease. Eur J Neurosci 2009, 29: 954\u2013963.","journal-title":"Eur J Neurosci"},{"key":"1342_CR127","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.2337\/db09-0143","volume":"58","author":"KSC Hamming","year":"2009","unstructured":"Hamming KSC, Soliman D, Matemisz LC, Niazi O, Lang Y, Gloyn AL, et al. Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel. Diabetes 2009, 58: 2419\u20132424.","journal-title":"Diabetes"},{"key":"1342_CR128","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1080\/13813455.2020.1789170","volume":"128","author":"A Zubov","year":"2022","unstructured":"Zubov A, Muruzheva Z, Tikhomirova M, Karpenko M. Glibenclamide as a neuroprotective antidementia drug. Arch Physiol Biochem 2022, 128: 1693\u20131696.","journal-title":"Arch Physiol Biochem"},{"key":"1342_CR129","doi-asserted-by":"crossref","unstructured":"Hill E, Gowers R, Richardson MJE, Wall MJ. \u03b1-synuclein aggregates increase the conductance of substantia nigra dopamine neurons, an effect partly reversed by the KATP channel inhibitor glibenclamide. eNeuro 2021, 8: ENEURO.0330\u2013ENEURO.0320.2020.","DOI":"10.1523\/ENEURO.0330-20.2020"},{"key":"1342_CR130","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1111\/jcmm.17784","volume":"27","author":"M Alrouji","year":"2023","unstructured":"Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Jabir MS, et al. NF-\u03baB\/NLRP3 inflammasome axis and risk of Parkinson\u2019s disease in Type 2 diabetes mellitus: A narrative review and new perspective. J Cell Mol Med. 2023, 27: 1775\u20131789.","journal-title":"J Cell Mol Med."},{"key":"1342_CR131","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2174\/157340708786305952","volume":"4","author":"CA Perez","year":"2008","unstructured":"Perez CA, Tong Y, Guo M. Iron chelators as potential therapeutic agents for Parkinson\u2019s disease. Curr Bioact Compd 2008, 4: 150\u2013158.","journal-title":"Curr Bioact Compd"},{"key":"1342_CR132","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3389\/fphar.2018.01030","volume":"9","author":"EJ Seo","year":"2018","unstructured":"Seo EJ, Sugimoto Y, Greten HJ, Efferth T. Repurposing of bromocriptine for cancer therapy. Front Pharmacol 2018, 9: 1030.","journal-title":"Front Pharmacol"},{"key":"1342_CR133","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2015.12.029","volume":"109","author":"F Lopez Vicchi","year":"2016","unstructured":"Lopez Vicchi F, Luque GM, Brie B, Nogueira JP, Garcia Tornadu I, Becu-Villalobos D. Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacol Res 2016, 109: 74\u201380.","journal-title":"Pharmacol Res"},{"key":"1342_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101241","volume":"51","author":"G Tavares","year":"2021","unstructured":"Tavares G, Marques D, Barra C, Rosendo-Silva D, Costa A, Rodrigues T, et al. Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes. Mol Metab 2021, 51: 101241.","journal-title":"Mol Metab"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-024-01342-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-024-01342-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-024-01342-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:51:08Z","timestamp":1744203068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-024-01342-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":134,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1007\/s12264-024-01342-8","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}